|
|
Article: Sanofi Pasteur Presents Positive Results of Tetravalent Dengue Candidate Vaccine.
- Article from:
- PR Newswire
- Article date:
- November 6, 2007
CopyrightCOPYRIGHT 2007 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
LYON, France, November 6 /PRNewswire-FirstCall/ -- Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced today positive results in the development of a vaccine for the global prevention of dengue fever, one of the most widespread tropical diseases. The results are being presented today at the American Society of Tropical Medicine and Hygiene (ASTMH)'s 56th annual meeting held in Philadelphia, Pennsylvania, USA.
These results have prompted Sanofi Pasteur to immediately expand ongoing clinical trials in Asia and Latin America. Submission to health authorities for registration is anticipated in 2012.
"Sanofi Pasteur made research for a ...
Related newspaper, magazine, and journal articles:
|
|
Article: Studies from Sanofi Pasteur, Research Department in ...
Vaccine Weekly;
August 27, 2008 ;
700+ words
... ... Mantel and colleagues, Sanofi Pasteur, Research Department ... contact N. Mantel, Sanofi Pasteur, Microbiology Research ... Vaccines, Biotechnology, Dengue Fever, Drug Development ... Pharmaceutical Company, Sanofi Pasteur, Therapy, Treatment ...
|
|